Smilow Cancer Hospital at Yale New Haven Hospital

New Haven, Connecticut

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Oncology Clinical Trial
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
Status: Enrolling, Phase II, III
Updated: 11/22/2016
Smilow Cancer Hospital at Yale New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
Status: Enrolling, Phase II
Updated: 12/31/1969
Smilow Cancer Hospital at Yale New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials